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Anthelmintica b s t r a c t
Parasitic nematodes cause chronic, debilitating infections in both livestock and humans worldwide, and
many have developed multiple resistance to the currently available anthelmintics. The protective collage-
nous cuticle of these parasites is required for nematode survival and its synthesis has been studied exten-
sively in the free-living nematode, Caenorhabditis elegans. The collagen synthesis pathway is a complex,
multi-step process involving numerous key enzymes, including the astacin metalloproteases. Nematode
astacinsare crucial for C. elegans development, having speciﬁc roles in hatching, moulting and cuticle syn-
thesis. NAS-35 (also called DPY-31) is a homologue of a vertebrate procollagen C-proteinase and performs
a central role in cuticle formation of C. elegans as its mutation causes temperature-sensitive lethality and
cuticle defects. The characterisation of DPY-31 from the ovine gastrointestinal nematode Teladorsagia cir-
cumcincta and its ability to rescue the C. elegans mutant is described. Compounds with a hydroxamate
functional group have previously been shown to be potent inhibitors of procollagen C-proteinases and
were therefore examined for inhibitory activity against the T. circumcincta enzyme. Phenotypic screening
against T. circumcincta, Haemonchus contortus and C. elegans larval stages identiﬁed compounds that
caused body morphology phenotypes consistent with the inhibition of proteases involved in cuticle col-
lagen synthesis. These compounds correspondingly inhibited the activity of recombinant T. circumcincta
DPY-31, supporting the hypothesis that this enzyme may represent a potentially novel anthelmintic drug
target.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Gastrointestinal (GI) nematodes cause chronic debilitating
infections in livestock and humans worldwide, having a major eco-
nomic impact on sheep farming resulting in loss of appetite, weight
loss, decreased wool, meat and milk production and death (Zajac,
2006; Roeber et al., 2013). Current treatment is through the use
of anthelmintic drugs (McKellar and Jackson, 2004); however,
multiple resistance to anthelmintics of the three major classes
has now developed in the veterinary parasites (Pomroy, 2006;
Papadopoulos et al., 2012). Only a limited number of new drugs
with novel modes of action have become available in recent years
(Besier, 2007; Epe and Kaminsky, 2013), thereby limiting future
prospects for effective control. No vaccines have yet beendeveloped against these infections, although many different mole-
cules have been under investigation for many years as potential
vaccine candidates (Dalton and Mulcahy, 2001; Diemert et al.,
2008; LeJambre et al., 2008).
All nematodes are surrounded by an external protective struc-
ture called the cuticle. The cuticle functions as an exoskeleton
and provides protection from the external environment during
development, hence its importance for nematode survival (Page
et al., 2014). Synthesis of this structure is a complex, multi-step
process, involving numerous enzymes (Page and Winter, 2003).
The cuticle is largely composed of collagens (Fetterer, 1989;
Johnstone, 2000), which are homologous between the free-living
nematode, Caenorhabditis elegans, and parasitic nematodes such
as the major GI nematodes of sheep, Teladorsagia circumcincta
(Johnstone et al., 1996) and Haemonchus contortus (Laing et al.,
2013). The process of cuticle biosynthesis has been studied in
detail in C. elegans (Page and Winter, 2003), with many of the cru-
cial cuticle synthesising enzymes and proteases also present in
parasitic nematodes (reviewed in Page et al., 2014), suggesting that
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and its parasitic counterparts.
Protease enzymes are essential for the continued development
and survival of nematodes in the host and fall into the following
main classes: aspartic, cysteine, metallo-, threonine and serine pro-
teases. The astacin metalloprotease enzymes play an essential role
in cuticle biosynthesis in C. elegans (Hishida et al., 1996; Davis
et al., 2004; Novelli et al., 2004, 2006; Suzuki et al., 2004). These
enzymes are structurally distinct zinc metallo-endopeptidases that
are characterised by two conservedmotifs in the N-terminal astacin
domain: the zinc-binding active site (HExxHxxGFxHExxRxDRD)
and the methionine-turn (SxMHY) (Bond and Beynon, 1995).
Binding of the zinc in the active site is essential for the catalytic
activity of the enzyme; this zinc is pentacoordinated in a trigonal–
bipyramidal geometry between the three histidine residues in the
binding motif, the tyrosine in the methionine-turn and a water
molecule (Bode et al., 1992). The ﬁrst astacin metalloprotease iden-
tiﬁed was found in the crayﬁsh, Astacus astacus, and consisted of a
signal peptide, prodomain and a catalytic protease domain contain-
ing both conserved catalytic motifs. Astacin metalloproteases con-
taining C-terminal domains of unknown functions, as well as the
N-terminal catalytic domain, have now been isolated from a range
of organisms including humans, mice, Drosophila melanogaster and
C. elegans (Stöcker et al., 1993; Möhrlen et al., 2003, 2006). The pri-
mary role in all species is in development (Bond and Beynon, 1995),
such as the hatching andmoulting of C. elegans (Hishida et al., 1996;
Davis et al., 2004; Suzuki et al., 2004). Functional roles for astacin
proteases in parasitic nematodes include host tissue penetration
by infective L3s (Williamson et al., 2006), cuticle formation and
ecdysis (Gamble et al., 1989; Stepek et al., 2010, 2011) and digestion
(Gallego et al., 2005).
There are 39 nematode astacin (NAS) metalloproteases
expressed in C. elegans, which are subdivided into six subgroups (I
to VI). Based on expression studies and RNA interference (RNAi),
many of these proteases play developmental roles in C. elegans
(Möhrlen et al., 2003). All the C. elegans NAS have a similar domain
arrangement: signal peptide, prodomain, N-terminal catalytic asta-
cin domain andmay include a combination of the following C-term-
inal domains: Epidermal Growth Factor (EGF), Complement
component Uegf and BMP-1 (CUB) and ThromboSPondin type-1
repeat (TSP-1) (Möhrlen et al., 2003). Removal of the prodomain
causes conformational changes to the astacin domain, which results
in enzyme activation (Guevara et al., 2010). The functions of the C-
terminal domains are largely unknown but these domains, whilst
having a non-catalytic purpose, are hypothesised to regulate the
catalytic activity of the enzyme, provide its speciﬁcity and deter-
mine when and where the protein performs its role (Wermter
et al., 2007). The subgroup V enzymes, NAS-33 to NAS-38, are found
only in nematodes and have a unique nematode-speciﬁc C-terminal
domain arrangement, consisting of one EGF, one CUB and one TSP-1
domain (Möhrlen et al., 2003). The enzyme NAS-34 is required for
embryo hatching (Hishida et al., 1996) and NAS-36 and NAS-37
are both crucial to the moulting process (Davis et al., 2004).
DPY-31 (also known as NAS-35) has similarities to the verte-
brate procollagen C-proteinase Bone Morphogenetic Protein-1
(BMP-1), which is critical for the assembly of collagen ﬁbres during
cartilage and bone formation through its excision of the C-terminal
domain of procollagen to form mature collagen (Li et al., 1996). In
C. elegans, dpy-31 is expressed throughout the life-cycle, particu-
larly in the embryonic and larval stages, in most hypodermal cells,
as well as the rectal and vulval epithelial cells (Novelli et al., 2004).
Caenorhabditis elegans dpy-31(e2770) mutants are inviable at the
standard growth temperature of 20 C and partially viable at
15 C, with survivors displaying severe body morphology defects
known as Dumpy (short and fat) (Novelli et al., 2004). Genetic sup-
pressor screens identiﬁed the DPY-31 cleavage site in theC-terminus of the essential cuticle collagen SQT-3 (Novelli et al.,
2006). The procollagens, such as SQT-3, in dpy-31(e2770) mutants
therefore remain partially processed and cannot form mature col-
lagens. Thus, DPY-31 plays a crucial role in cuticle formation and
the moulting process in C. elegans. Earlier work has indicated that
hydroxamate-based compounds are highly effective inhibitors of
procollagen C-proteinase (Ovens et al., 2000; Fish et al., 2007;
Bailey et al., 2008), suggesting that these compounds may also be
effective against the nematode DPY-31 enzymes.
Here we identify and characterise the DPY-31 orthologue from
the important GI nematode of sheep, T. circumcincta. The naturally
occurring hydroxamic acid, actinonin (Gordon et al., 1975), and
other developed inhibitory compounds containing a hydroxamate
functional group (Fish et al., 2007) were screened against recombi-
nant T. circumcincta DPY-31 and against larval stages of T. circum-
cincta, H. contortus and C. elegans to determine their effectiveness
as inhibitors of this key developmental enzyme.2. Materials and methods
2.1. Nematode strains and culture
Caenorhabditis elegans was cultured as described previously
(Stiernagle, 2006), with the strains N2 (wild-type), HT1593 (unc-
119(ed3) III) and DR96 (unc-76(e911) V) provided by the
Caenorhabditis Genetics Center (CGC), USA. The C. elegans dpy-
31(e2770) strain was provided by Professor Jonathan Hodgkin,
University of Oxford, UK.
Teladorsagia circumcincta MTci2 and H. contortus ISE strains
were provided by Professor David Knox (Moredun Research
Institute, UK). Nematode eggs were extracted from infected sheep
faeces using a salt ﬂotation protocol and L1s were allowed to hatch
in tap water at approximately 25 C overnight. These L1s were
cleaned free from eggs and faecal matter by passing down a
Baermann apparatus overnight. Active, healthy T. circumcincta
L3s (<6 months old) were exsheathed by exposure to CO2, as
detailed in Halliday et al. (2012), except that the larvae were ini-
tially activated at 40 C in a New Brunswick Scientiﬁc, USA (E24
Series) shaker at 60 rpm for 15 min, exposed to CO2 in a total vol-
ume of 5 ml, and then incubated at 40 C with shaking at 100 rpm
for 90 min. The exsheathment progress of a 20 ll sample was
monitored under a Zeiss dissecting microscope.
2.2. Preparation of genomic DNA, RNA and cDNA
Genomic DNA was isolated from adult T. circumcincta (MTci5)
by homogenisation in Proteinase K and repeated phe-
nol:chloroform extractions, as described previously (Stepek et al.,
2010). For RNA, adult nematodes, L3s or L1s were disrupted in
TRIzol (Life Technologies, UK) using a hand-held Pestle and
Motor Mixer (VWR, UK) with 1.5 ml disposable pestles and
screw-capped tubes (VWR), and total RNA isolated following the
TRIzol (Life Technologies) protocol. cDNA was prepared using an
AfﬁnityScript Multiple Temperature cDNA synthesis kit (Agilent
Technologies, USA).
2.3. Identiﬁcation of the coding and genomic sequences of
T. circumcincta dpy-31
The C. elegans DPY-31 protein sequence was used to tBLASTn
search the T. circumcincta database (M. Mitreva, Washington
University School of Medicine, USA, personal communication).
The supercontig0014679 and scaffold00169 had the highest
homology score, and potential intron–exon splice sites were pre-
dicted using GeneWise2 (http://www.ebi.ac.uk/Tools/psa/
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gans protein sequence using ClustalX and BoxShade (http://www.
ch.embnet.org/software/BOX_form.html). Ampliﬁcation of the 50
and 30 ends of the T. circumcincta dpy-31 gene was performed using
the 50 and 30 RACE Systems for Rapid Ampliﬁcation of cDNA Ends
(Life Technologies) with the primers dpy-31501, dpy-31502 and
dpy-31a30 (Supplementary Table S1). Gene Structure Draw
(http://www.compgen.uni-muenster.de/tools/strdraw/?bscl=false&
lang=en&mscl=0&cscl=0) was used to produce a scaled schematic
depicting the positions of the introns and exons.
DPY-31 orthologues from across the nematode phylum were
identiﬁed using BLASTp with C. elegans DPY-31 as a query in
WormBase (http://www.wormbase.org/tools/blast_blat), the
Wellcome Trust Sanger Institute, UK (http://www.sanger.ac.uk/re-
sources/software/blast/) and GenBank (http://www.ncbi.nlm.nih.
gov/BLAST/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch&
LINK_LOC=blasthome). These sequences were aligned using
ClustalX2 and a phylogenetic tree generated using ClustalW2 –
Phylogeny (http://www.ebi.ac.uk/Tools/phylogeny/clustalw2_phyl
ogeny/) and Phylodendron (Phylogenetic tree printer; http://iu-
bio.bio.indiana.edu/treeapp/treeprint-form.html).
2.4. Generation of integrated transgenic C. elegans lines with a
T. circumcincta dpy-31 rescue plasmid using microparticle
bombardment
Plasmid pnas-35, containing the C. elegans dpy-31 promoter and
30 untranslated region (UTR), was constructed as described pre-
viously (Stepek et al., 2010). The coding sequence of the T. circum-
cincta dpy-31 gene was ampliﬁed from T. circumcincta cDNA by PCR
using the primers Tcdpy-31SbfIF and Tc35aR (Supplementary
Table S1) and PfuUltra polymerase. The 1845 bp product was
cloned into plasmid pCR-TOPO2.1 (Life Technologies), a synthetic
intron inserted by ligation of a double-stranded oligonucleotide
(50-gtaagtttaaactattcgttactaactaactttaaacatttaaattttcag-30) into a
PmlI restriction site, and then subcloned into pnas-35 using SbfI
and NotI sites to create the T. circumcincta dpy-31 rescue construct,
named Tcdpy-31 + SI/pnas-35. This plasmid was sequenced over
junctions using the primers Ce35pinF, Ce35uinR and Tcdpy-
31SIseqF (Supplementary Table S1).
Transgenic C. elegans lines were generated with the plasmid
Tcdpy-31 + SI/pnas-35 using a microparticle bombardment method
essentially as described (Praitis, 2006). Brieﬂy, the C. elegans
mutant strain HT1593 (unc-119(ed3)) was grown in liquid culture
using Escherichia coli strain HB101 (Praitis, 2006; Stiernagle,
2006), and microparticle bombardment was performed using the
biolistic PDS-100/He particle delivery system with a Hepta
Adaptor, using 5 lg of Tcdpy-31 + SI/pnas-35 and 5 lg of
pDPMM016b (unc-119(+), rescue plasmid) (Maduro and Pilgrim,
1995). The bombarded worms were incubated at 25 C for
>2 weeks, after which non-Unc dauers were cloned. Three inte-
grated strains, TP204, TP205 and TP207, were isolated and the
presence of the parasite gene conﬁrmed by single-worm PCR
(Williams et al., 1992) with the primers Tcdpy-31SbfI F and
Tc35aR. Strain TP224 (dpy-31(e2770) III; kaIs8[Tcdpy-31 + SI/pnas-
35 + unc-119(+)]) was created by crossing TP205 (Tcdpy-31 + SI/
pnas-35 + unc-119(+)) and dpy-31(e2770) at 15 C. The transgene
was followed through crosses by single-worm PCR (primers as
above) and the dpy-31(e2770) allele followed using allele-speciﬁc
PCR (Gaudet et al., 2009) with the primers dpy-31F, dpy-31(M)F
and dpy-31R2 (Supplementary Table S1). Homozygosity of the
transgene was demonstrated by transmission to 100% of progeny
tested (n = 20). To conﬁrm the function of T. circumcincta dpy-31
in the strain TP224, the T. circumcincta dpy-31 RNAi plasmid
(Tcdpy-31 insert subcloned into the RNAi vector, L4440) was trans-
formed into bacterial strain HT115(DE3) and RNAi feeding wasperformed on the N2 and TP224 strains at 20 C. HT115(DE3) cells
containing the RNAi vector without an insert was used as a nega-
tive control.2.5. Generation of transgenic C. elegans lines with a T. circumcincta
dpy-31 promoter–reporter plasmid by microinjection
A 1626 bp fragment was ampliﬁed from T. circumcincta genomic
DNA (positions 1617 to +9 relative to the dpy-31 ATG start) using
primers Tcdpy-31repF2 and Tcdpy-31repR2 (Supplementary
Table S1), cloned into the reporter gene vector pPD96:04
(lacZ::gfp; Addgene) using SmaI and SalI restriction sites, and
sequenced using the primers Reporter seq and M13Rev(-29)
(Supplementary Table S1). This construct was microinjected into
the syncytial gonad of C. elegans strain DR96 (unc-76(e911) V) at
100 lg/ml together with p7616B (unc-76(+), rescue plasmid) at
100 lg/ml. Three transgenic lines were identiﬁed and examined
for reporter gene expression by staining glutaraldehyde-ﬁxed
worms for b-galactosidase activity (Hope, 1991).2.6. Recombinant expression of T. circumcincta DPY-31
A 684 bp synthetic gene encoding the astacin domain of T. cir-
cumcincta DPY-31, with codons optimised for E. coli, was generated
by GeneArt (Life Technologies, UK) and cloned into the pET-28a(+)
vector (Novagen, Germany) using NdeI and XhoI. This construct
was fully sequenced, transformed into E. coli BL21 (DE3) cells,
and recombinant protein expression induced with 0.5 mM iso-
propyl b-D-1-thiogalactopyranoside (IPTG) at 16 C, 250 rpm over-
night. Cells were harvested and stored at 80 C then resuspended
in native lysis buffer, pH 8.0 (50 mM NaH2PO4, 300 mM NaCl,
10 mM imidazole), 1.7 mg/ml of lysozyme and 0.1 mg/ml of
DNaseI. The lysed cells were sonicated and puriﬁcation of the pro-
tein from the soluble cell lysate was performed using Ni-NTA resin
columns (Qiagen, UK) under native conditions, with 20 mM imida-
zole in the wash buffer (50 mM NaH2PO4, 300 mM NaCl) and
250 mM imidazole in the elution buffer (50 mM NaH2PO4,
300 mM NaCl). The eluates were concentrated together using a
10 kDa cut-off concentrator (Millipore, Germany) and then anal-
ysed by SDS–PAGE and Western blotting using an anti-histidine
(His) G antibody (Life Technologies, UK) and an anti-mouse
IgG (whole molecule) alkaline phosphatase conjugate (Sigma,
UK). Protein concentration was determined using the Bradford
assay.2.7. Zinc metalloprotease activity assays
Zinc metalloprotease assays were performed on recombinant T.
circumcincta DPY-31 using an adapted method (Gamble et al.,
1989, 1996; Stöcker and Zwilling, 1995). Brieﬂy, 0, 25, 50, 100 or
200 lg/ml of recombinant enzyme were incubated with 0.1 mM
ZnCl2, and the total volume was made up to 100 ll with 50 mM
NaPO4, pH 8.0 buffer prior to the addition of 1 mM synthetic sub-
strate, Suc-Ala-Ala-Ala-pNA (Bachem, Germany), and incubation at
37 C for 3 h. Each sample was performed in duplicate and the
absorbance was measured on a plate reader at 405 nm. A second
assay involved incubating 150 lg/ml of recombinant enzyme with
0.1 mM ZnCl2 and 0, 25, 50, 100 or 200 lM inhibitor, 1,10-phenan-
throline, with the volume made up to a total of 100 ll with 50 mM
NaPO4, pH 8.0 buffer. Pre-incubation occurred for 3 h at 37 C prior
to the addition of 1 mM Suc-Ala-Ala-Ala-pNA and subsequent
incubation at 37 C for a further 3 h. Each sample was performed
in duplicate and the absorbance was measured on a plate reader
at 405 nm.
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T. circumcincta DPY-31
Actinonin and four further hydroxamate-based compounds that
have exhibited procollagen C-proteinase inhibition (compounds 1,
25, 26 and 56 described in Fish et al. (2007)) were made up in 50–
100% ethanol and tested in an astacin assay to determine their abil-
ity to inhibit recombinant T. circumcincta DPY-31. Brieﬂy, 150 lg/
ml of recombinant enzyme was incubated with 0.1 mM ZnCl2
and compound at concentrations ranging from 5 lM to 100 lM,
and the volume was made up to a total of 100 ll with 50 mM
NaPO4, pH 8.0 buffer. Pre-incubation occurred for 3 h at 37 C prior
to the addition of 1 mM Suc-Ala-Ala-Ala-pNA (Bachem) and subse-
quent incubation at 37 C for a further 3 h. Absorbance was mea-
sured on a plate reader at 405 nm, with each sample performed
in duplicate.
2.9. In vivo screening of compounds
The ﬁve compounds described in Section 2.8 were screened
against C. elegans wild-type (N2) or T. circumcincta-rescued dpy-
31 mutants (strain TP224) using 96-well plates. Caenorhabditis ele-
gans L4s were placed into each of the wells in a total volume of
100 ll, made up of compound, M9 buffer and 5 ll of 10 concen-
trated food (E. coli strain OP50). Each compound was tested in
duplicate at concentrations ranging from 50 lM to 2 mM. The
plates were sealed with gas-permeable covers and incubated at
20 C for 3 days, with viability and gross morphology of the F1 pro-
geny recorded daily. On day 3, representative offspring were trans-
ferred onto 2% agarose/0.01% azide pads on slides and viewed by
microscopy.
2.10. Screening of compounds against T. circumcincta and H. contortus
larvae
L1s or exsheathed L3s of T. circumcincta and H. contortus were
incubated with the same compounds as in Section 2.9. Each com-
pound was tested in duplicate at concentrations ranging from
50 lM to 2 mM for both L1s and exsheathed L3s. L1s were incu-
bated, 10–20 per well of a 96-well plate, each well containing com-
pound, 5 ll of 10 concentrated OP50 and Earles Balanced Salt
Solution (EBSS, Life Technologies) to 100 ll; or 10–20 exsheathed
L3s were incubated per well of a 96-well plate, each well contain-
ing compound and EBSS to 100 ll. The plates were sealed with gas-
permeable covers and incubated at 26 C (L1s) or 40 C (L3s) at
100 rpm for 7–8 days and any observations on development were
recorded. Representative worm images were taken as stated in
Section 2.9.
2.11. Microscopy
Live nematodes, mounted on 2% agarose/0.01% azide pads, or
ﬁxed nematodes, were viewed under Differential Interference
Contrast (DIC) or ﬂuorescence (GFP) optics on a Zeiss Axioskop2
microscope, and images were taken using an AxioCam camera
and Axiovision software.3. Results
3.1. Identiﬁcation of T. circumcincta dpy-31
Following BLAST searches in the T. circumcincta database, a dpy-
31 orthologue was identiﬁed and its sequence conﬁrmed by 50- and
30-RACE and ampliﬁcation of a full-length PCR product. Although
two 30 alternatively-spliced forms (A and B) of dpy-31 have beenisolated from C. elegans, only isoform A was found in T. circum-
cincta. The T. circumcincta dpy-31 gene is 17,346 bp, consisting of
16 exons (data not shown) compared with the C. elegans gene,
which is 5003 bp and eight exons. The full-length coding
sequences for dpy-31 in T. circumcincta and C. elegans are 1845 bp
and 1779 bp, and encode polypeptides of 614 and 592 amino acids,
respectively. Signal peptide cleavage sites and pro-domain cleav-
age sites for T. circumcincta DPY-31 were predicted using the
SignalP and ProP programs (Fig. 1A). Thus, the predicted mature
proteins for DPY-31 consist of 465 and 466 amino acids for T. cir-
cumcincta and C. elegans, respectively, having an identity of
85.4%. The size and pIs of the mature DPY-31 proteins, calculated
using Compute pI/MW (http://web.expasy.org/compute_pi/), are
52.3 kDa and 52.6 kDa, and 7.71 and 8.16 for T. circumcincta and
C. elegans, respectively. The DPY-31 proteins from both T. circum-
cincta and C. elegans have an N-terminal catalytic astacin domain
(Pfam PF01400), containing the crucial zinc-binding site which is
characterised by the sequence HExxHxxGFxHExxRxDRD, and a
conservedmethionine-turn (SxMHY), of which the tyrosine residue
forms one of the ﬁve important ligands essential to bind the active-
site zinc. In addition to the essential catalytic domain, the DPY-31
proteins also contain successive EGF, CUB and TSP-1 domains at
the C-terminal (Fig. 1A).
A phylogenetic tree, shown in Fig. 1B, was generated with DPY-
31 orthologues from nematode species across the phylum. Fig. 1B
indicates that DPY-31 orthologues are largely organised into the
different nematode clades, with identity to C. elegans DPY-31 rang-
ing from 57% in Clade I to 100% in Clade V. The presence of DPY-31
orthologues throughout the nematode phylum supports a con-
served, crucial role for this protease during nematode
development.3.2. Complementation of the C. elegans dpy-31 mutant with the
T. circumcincta dpy-31 gene
The complex lifecycles of parasitic nematodes, such as T. cir-
cumcincta, make them less amenable to experimental analysis. To
overcome these difﬁculties, C. elegans was applied as a surrogate
experimental system. The C. elegans dpy-31(e2770) mutant is a
temperature-sensitive larval lethal strain that is non-viable at
20 C and barely viable at 15 C, with all surviving worms exhibit-
ing a strong recessive body morphology phenotype known as
Dumpy (Novelli et al., 2004). Introduction of T. circumcincta dpy-
31 into the C. elegans dpy-31(e2770) strain fully repaired the lethal-
ity and body morphology phenotypes of this mutant. Rescued
strains were conﬁrmed as homozygous for mutation in endoge-
nous C. elegans dpy-31 by allele-speciﬁc single-worm PCR. Fig. 2A
shows a wild-type C. elegans N2, while Fig. 2B shows the Dumpy
phenotype of the dpy-31(e2770) mutant at 15 C. These images
were compared with Fig. 2C to indicate that the T. circumcincta
dpy-31 gene was able to rescue the dpy-31(e2770) mutant at the
normally non-permissive temperature of 20 C. Fig. 2D shows sin-
gle-worm PCR of representative rescued worms (TP224) and com-
pares them with the original mutant dpy-31(e2770) and wild-type
(N2) backgrounds. Primers were able to detect the presence of the
T. circumcincta dpy-31 transgene in 100% of the progeny tested, but
not in either the N2 or dpy-31(e2770) strains (Fig. 2Da); allele-
speciﬁc genotyping primers indicated that the dpy-31(e2770) allele
is a homozygous mutant in both TP224 and the original dpy-
31(e2770) mutant, but wild-type in N2 (Fig. 2Db). Conﬁrmation
that the T. circumcincta dpy-31 gene was required for the comple-
mentation of the TP224 strain was provided when this strain was
subjected to T. circumcincta dpy-31 RNAi, with the resultant pro-
geny returning to a mutant Dumpy phenotype with a penetrance
ranging from 60% to 100% (Fig. 2E). This supports the hypothesis
Fig. 1. Comparison of nematode DPY-31 proteins. (A) Alignment of DPY-31 from Caenorhabditis elegans and Teladorsagia circumcincta. Alignment was performed in ClustalW
and BoxShade, with identical amino acids shaded black and similar amino acids shaded grey. The signal peptide (SP) and prodomain (ProP) are indicated by arrows. The
catalytic active site and conserved methionine turn are labelled with HExxHxxGFxHExxRxDRD and SxMHY above the sequence, respectively. The domains are highlighted as
follows: grey box, astacin domain; ⁄ below the sequence, Epidermal Growth Factor domain; ^ below the sequence, Complement component Uegf and BMP-1 domain; and +
below the sequence, ThromboSPondin type-1 repeat domain. (B) Phylogenetic analysis of protein sequence data illustrating the relationship of DPY-31 between parasitic and
free-living nematodes across phylogenetic clades, I, III, IV and V. DPY-31 sequences were obtained via BLASTp of databases at WormBase, the Wellcome Trust Sanger Institute,
UK and GenBank, and were then aligned using ClustalX2 and arranged in a phylogenetic tree using ClustalW2 (Phylogeny) and Phylodendron. GenBank Accession Numbers: C.
elegans isoform A (CCD70758), C. elegans isoform B (CCD70759), Caenorhabditis brenneri (EGT53190.1), Caenorhabditis briggsae (XP 002641922.1), Caenorhabditis remanei (XP
003112951.1), Caenorhabditis japonica (CJP-DPY-31), Caenorhabditis angaria (Cang_2012_03_13_00993.g15272.t2), Caenorhabditis tropicalis (Csp11.scaffold489.g2034.t1),
Caenorhabditis sp5 (Csp5_scaffold_00350.g9906.t1), T. circumcincta (KM272923), Ancylostoma ceylanicum (EYC02674.1), Haemonchus contortus isoform 1 (CDJ87214.1), H.
contortus isoform 2 (CDJ95996.1), Heterorhabditis bacteriophora (ABY74338.1), Necator americanus (ETN74486.1), Pristionchus paciﬁcus (PPA-DPY-31), Pristionchus exspectatus
(scaffold21_EXSNAP2012.38), Ascaris suum (ADY45142), Brugia malayi isoform A (ACZ64270.1), B. malayi isoform B (ACZ64271.1),Wuchereria bancrofti (EJW84352.1), Loa loa
(EF026205), Onchocerca volvulus (OVO-DPY-31), Trichinella spiralis (EFV57669), Trichuris trichiura (CDW53272.1), Strongyloides ratti (CEF68555.1), Meloidogyne hapla
(MhA1_contig704.frz3.gene1), Meloidogyne incognita (Minc01936) and Bursaphelenchus xylophilus (BUX.s00351.406).
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Fig. 2. Complementation of a Caenorhabditis elegans dpy-31(e2770) mutant with Teladorsagia circumcincta (Tc) dpy-31. A C. elegans (Ce) dpy-31(e2770) mutant was crossed
with an integrated transgenic line carrying the wild-type Tc dpy-31 gene. (A) An adult N2 at 20 C; (B) an adult dpy-31(e2770) mutant at 15 C; and (C) an adult TP224 (T.
circumcincta-rescued dpy-31(e2770)mutant) at 20 C. (D) A single-worm allele-speciﬁc PCR is shown to demonstrate the presence of the Tc dpy-31 gene and Ce dpy-31(e2770)
mutant allele in TP224 (lane 1, representative TP224 F3; lane 2, adult N2; and lane 3, adult dpy-31(e2770)). (a) The presence of the Tc dpy-31 gene in the TP224 transgenic
strain, but not in N2 wild-type or dpy-31(e2770) mutant strains is shown. (b) The dpy-31(e2770) allele is a homozygous mutant in both the transgenic TP224 strain and the
original dpy-31(e2770) mutant, but wild-type in the N2 strain. (E) Tc dpy-31 RNA interference by feeding the rescued TP224 wild-type transgenic strain reverts back to the
mutant phenotype.
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function as dpy-31 in C. elegans.3.3. Heterologous expression of the T. circumcincta dpy-31 promoter–
reporter in C. elegans
A T. circumcincta dpy-31 promoter–reporter construct was used
to examine tissue-speciﬁc localisation by its ability to direct spatial
expression in C. elegans. Detectable transgene expression is pre-
dominantly restricted to the pharyngeal gland cells and the rectal
epithelial cells of C. elegans, as demonstrated by b-galactosidase
staining of transgenic C. elegans (Fig. 3). This expression pattern
was consistent throughout all life-cycle stages, in particular
embryos and larvae (Fig. 3), and is consistent with a nematodeenzyme that is expressed in the posterior gut and the glandular
excretory/secretory system.
3.4. Recombinant expression of T. circumcincta DPY-31
The T. circumcincta DPY-31 catalytic astacin domain was cloned
into the pET-28a(+) vector for expression in E. coli, and the His-
tagged recombinant protein induced using IPTG. The correspond-
ing Ni-NTA column-puriﬁed 23 kDa protein was detected by
Western blotting following probing with an anti-His antibody
(Fig. 4D). The resulting puriﬁed recombinant protein was found
to be active in an astacin activity assay against a synthetic peptide
substrate (Fig. 4A). Metalloprotease activity was zinc-dependent
and was weakly but progressively inhibited by the general zinc
metalloprotease inhibitor, 1,10-phenanthroline (Fig. 4B). This
Fig. 4. Metalloprotease activity of recombinant DPY-31 from Teladorsagia circumcincta in the presence and absence of inhibitory compounds. (A) An increase in absorbance is
shown as the concentration of recombinant protein also increases from 25 to 200 lg/ml. (B) The progressive inhibition of recombinant Tc DPY-31 (150 lg/ml)
metalloprotease activity in the presence of increasing concentrations (25–200 lM) of the general metalloprotease inhibitor, 1,10-phenanthroline is shown. (C) The effect on
metalloprotease activity of 150 lg/ml of recombinant protein on incubation with increasing concentrations of inhibitory hydroxamate-containing compounds 25 and 26 is
shown. (D) Coomassie staining of histidine (His) column-eluted recombinant Tc DPY-31 (lane 1) and an anti-His tag Western blot of eluted recombinant Tc DPY-31 (lane 2).
Arrow indicates recombinant protein.
Fig. 3. Promoter–reporter expression of Teladorsagia circumcincta DPY-31 in Caenorhabditis elegans. Approximately 2 kb of the T. circumcincta dpy-31 promoter was cloned
into the reporter vector, pPD96:04, and C. elegans transgenic lines established. Following b-galactosidase staining, expression was apparent in three independent lines, and
throughout the life-cycle stages. Representative images of larvae and embryos are depicted in (A) and (B). The arrows indicate expression in the pharyngeal gland cells and
rectal epithelial cells.
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352 G. Stepek et al. / International Journal for Parasitology 45 (2015) 345–355result conﬁrms that DPY-31 from the parasitic nematode, T. cir-
cumcincta, is indeed a speciﬁc, functionally-active, zinc
metalloprotease.3.5. Screening of compounds with potential to inhibit nematode
astacin metalloproteases
Actinonin and procollagen metalloprotease inhibitors 1, 25, 26
and 56 (Fish et al., 2007) have proven to be effective, reversible
inhibitors of astacins and procollagen C-peptidases. These ﬁve
compounds were screened against the recombinant T. circumcincta
DPY-31 protein (Table 1) and, as can be seen in Fig. 4C, compound
26 was the most efﬁcacious, displaying more potent inhibition
than the hydroxamate-based inhibitor, actinonin. Compounds 25,
26 and actinonin had a much greater inhibitory activity against
recombinant DPY-31 than the generic metalloprotease inhibitor,
1,10-phenanthroline (Fig. 4B, C), suggesting that recombinant
DPY-31 has greater binding speciﬁcity to compounds with a hydro-
xamate functional group than to those without this functional
group. The related hydroxamate compounds 1 and 56, however,
consistently proved to be ineffective at inhibiting the activity of
recombinant T. circumcincta DPY-31 (Table 1). This indicates, that
in addition to the hydroxamate structure, adjacent functional
groups may play a role in the speciﬁcity.
When these same ﬁve compounds were screened against the
L4s of C. elegans wild-type (N2) and T. circumcincta-rescued dpy-
31(e2770) mutants (C. elegans strain TP224), Dumpy worms and
cuticle defects (Moult) were observed (Table 1; Fig. 5A–C). These
effects were similar for both of the C. elegans strains being tested,
with the weakest effects being observed with compounds 1 and
56, and being consistent with their poor inhibition of the recombi-
nant enzymes. When compounds 25 and actinonin were screened
against the L1 and exsheathed L3 of T. circumcincta and against the
L1 of H. contortus, these worms became immobile and had a sick
appearance. These nematodes also showed a range of MoultTable 1
Compounds with inhibitory activity against Caenorhabditis elegans L4-derived offspring (N
Compound Structurea Effect against C. elegans L4 proge
N2 TP224b
Actinonin SLO; STE; DPY/MLT SLO; STE
Compound 1 SLO; DPY SLO; STE
Compound 56 SLO; STE; DPY SLO; STE
Compound 26 SLO; LET; DPY SLO; LET
Compound 25 SLO; STE; DPY/MLT SLO; STE
1,10-phenanthroline SLO; LET SLO; LET
dH2O WT WT
5% Ethanol WT WT
a Hydroxamate functional group is highlighted in bold and grey.
b TP224, dpy-31(e2770) rescued with T. circumcincta dpy-31.
c Phenotypes observed wereWT, wild-type; DPY, shorter, fatter body length compared
number of progeny; SLO, immobile; LET, larval lethal (no further development due to d
d LC50 values in brackets where it was possible to calculate those; x, no effect.(Fig. 5H) and Dumpy (Fig. 5E, F, I) phenotypes compared with the
control worms (Fig. 5D, G). The results of the larval screens would
suggest that the DPY-31 enzyme has the same crucial role during
the development of both parasitic and free-living nematodes.4. Discussion
Astacin metalloproteases play critical roles in cuticle synthesis
and moulting in C. elegans (Hishida et al., 1996; Davis et al.,
2004; Novelli et al., 2004; Suzuki et al., 2004) and parasitic nema-
todes (Stepek et al., 2010, 2011), with the astacin metalloprotease
DPY-31 being essential for the procollagen cleavage step of cuticle
synthesis (Novelli et al., 2006). In support of their importance in
parasitic nematode development, related astacin-like metallopro-
teases have been independently identiﬁed as potential nematode
vaccine candidates (Hotez et al., 2003; Barnard et al., 2012). Our
previous analysis reported a high degree of functional conservation
between DPY-31 from C. elegans, the ovine GI nematode H. contor-
tus, and the human ﬁlarial nematode Brugia malayi (Stepek et al.,
2010). This current study describes the detailed identiﬁcation
and characterisation of DPY-31 from the major GI nematode of
sheep, T. circumcincta, and the identiﬁcation of new inhibitors
against this enzyme that may represent a starting point for devel-
opment of novel chemotherapeutic agents.
Identity of 74% was noted between DPY-31 from C. elegans and
T. circumcincta, compared with 70% between C. elegans and H. con-
tortus (Stepek et al., 2010) and 89% between the proteins from T.
circumcincta and H. contortus. This level of identity is consistent
with the fact that all three species belong to nematode clade V.
As discovered for the dpy-31 genes from H. contortus and B. malayi
(Stepek et al., 2010), dpy-31 from T. circumcincta is much larger
than the C. elegans gene; this is due to an increase in both the size
and number of introns, and the completed genome of H. contortus
conﬁrms this to be a common feature in this parasite (Laing et al.,
2013).2 and TP224), and Teladorsagia circumcincta L1, L3 and recombinant DPY-31 protein.
nyc Effect against T.
circumcinctac
Effective concentration
against T. circumcincta rDPY-31d
L1 L3
; DPY/MLT SLO; DPY DPY/MLT; Sick 50–100 lM (50 lM)
; DPY ND ND x
; DPY ND ND x
; DPY ND ND 50 lM (33 lM)
; DPY/MLT SLO DPY/MLT; Sick 100 lM (82 lM)
SLO WT 100 lM
WT WT x
WT WT x
with wild-type; MLT, old cuticle retained by new larval stage; STE, sterile or reduced
eath of larva); Sick, lethargic; ND, Not determined.
Fig. 5. Effect of metalloprotease inhibitors on the development of Caenorhabditis elegans, Teladorsagia circumcincta and Haemonchus contortus larvae. (A–C) Caenorhabditis
elegans; (D–F) T. circumcincta; (G–I) H. contortus. (A) A wild-type L2 offspring in the absence of compound at 3 days is shown, and (D and G) show wild-type L3s in the absence
of compound at 7 days. (B) A L2 offspring with a Moult (Mlt) defect on incubation with 100 lM actinonin for 3 days is shown. (E) A L3 with a mild Dumpy (Dpy) defect on
incubation with 500 lM actinonin for 7 days, and (H) a L3 with a Mlt defect on incubation with 200 lM actinonin for 7 days. (C) A L4 offspring with a Mlt defect on incubation
with 300 lM compound 25 for 3 days, (F) a L3 with a mild Dumpy phenotype on incubation with 100 lM compound 25 for 7 days, and (I) a L3 with a strong Dumpy
phenotype on incubation with 500 lM compound 25 for 7 days. Mlt defects in (B, C and H) are indicated by white arrows.
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in C. elegans indicates that the expression of DPY-31 in T. circum-
cincta is analogous to that described for B. malayi, which was also
determined using C. elegans as a surrogate system (Stepek et al.,
2010); this expression was mainly observed in the pharyngeal
gland cells and rectal epithelial cells throughout the life-cycle.
This expression pattern overlaps with DPY-31 expression in C. ele-
gans, although DPY-31 is also expressed in the hypodermis in the
free-living species (Novelli et al., 2004). This partially shared
expression pattern is consistent with a role for DPY-31 in nema-
tode development since other proteases involved in cuticle synthe-
sis of C. elegans, such as the astacin metalloproteases NAS-36 and
NAS-37, are also present in the hypodermal cells, the pharyngeal
and rectal epithelial cells (Davis et al., 2004; Suzuki et al., 2004).
Thus, the expression pattern of DPY-31 in parasitic and free-living
nematodes is consistent with a role in cuticle synthesis and this is
further supported following C. elegans mutant rescue experiments.
The T. circumcincta dpy-31 gene was able to fully complement the
temperature-sensitive phenotype of the C. elegans dpy-31(e2770)
mutant by returning the wild-type form at the non-permissive
temperature. RNAi knockdown of T. circumcincta dpy-31 in thisstrain resulted in reversion to the mutant phenotype, supporting
the hypothesis that dpy-31 performs the same critical developmen-
tal role in parasitic nematodes as has been established in C. elegans.
This provides compelling evidence to support the functional con-
servation of DPY-31 between parasitic nematodes and C. elegans.
The nematode DPY-31 enzymes share similarities with the ver-
tebrate procollagen C-proteinase, BMP-1 (Novelli et al., 2004).
BMP-1 is a vertebrate enzyme involved in bone formation through
its ability to cleave the carboxyl terminal domains of procollagens
(Li et al., 1996). In C. elegans, dpy-31 genetic suppressor screens
identiﬁed that this enzyme cleaved the short C-terminal domain
of the essential cuticle collagen, SQT-3 (Novelli et al., 2006). This
role was supported following in vitro cleavage experiments with
recombinant DPY-31 from B. malayi and H. contortus (Stepek
et al., 2010), indicating functional conservation of DPY-31 through-
out the nematode phylum. This conserved nematode-speciﬁc func-
tion for DPY-31 makes this protease an ideal candidate as a target
for new anti-nematode drugs. Following the discovery that hydro-
xamate-based compounds are effective inhibitors of homologous
vertebrate procollagen C-proteinases (Ovens et al., 2000; Fish
et al., 2007; Bailey et al., 2008), this current study established
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known matrix metalloproteinase inhibitory activity against C. ele-
gans, T. circumcincta and H. contortus larvae and against recombi-
nant T. circumcincta DPY-31 enzyme. Four of these compounds
(1, 56, 25 and 26) were speciﬁcally developed to target procollagen
C-proteinases (Fish et al., 2007) and two of these (25, 26) were the
most potent inhibitors of recombinant DPY-31 from T. circum-
cincta. The effective concentrations of these inhibitors in vitro
and in vivo were found to be in the micromolar range compared
with the nanomolar range reported for the vertebrate enzymes
(Fish et al., 2007). Nonetheless, the in vivo correlations between
inhibitor phenotypes and the genetic mutants indicate that this
is a promising starting point from which to develop more nema-
tode-speciﬁc inhibitors. The phenotypic defects were comparable
between C. elegans and a C. elegans dpy-31 mutant rescued with
the T. circumcincta dpy-31 gene and more importantly, were consis-
tently similar in T. circumcincta larvae. This suggests that the cru-
cial role that DPY-31 plays in cuticle synthesis is conserved
between these diverse free-living and parasitic nematodes, and is
substantiated by the similar efﬁcacy of these compounds against
a second major GI nematode of sheep, H. contortus. The procollagen
C-proteinase inhibitors 25 and 26 share an extra aromatic ring
adjacent to the oxadiazole ring, a structure that is absent in the
otherwise related compounds 1 and 56, and this may account for
the enzyme speciﬁcity since additional pi-stacking interactions or
H-bond interactions may be occurring through this structure.
Thus, further investigations are warranted to establish whether
members of this sub-class of hydroxamate-based inhibitors have
potential promise as new drugs against nematode infections.
In conclusion, DPY-31 is a crucial procollagen C-proteinase in C.
elegans and in parasitic nematodes that is involved in cuticle for-
mation, most probably through the C-terminal cleavage of pro-
collagens to form mature collagens. This present study, together
with our previous report (Stepek et al., 2010), demonstrates that
the function of DPY-31 is conserved throughout the nematode phy-
lum and, hence, this enzyme class may represent an ideal target for
future nematode control. This current study has demonstrated that
a subset of hydroxamate-based compounds are effective inhibitors
of DPY-31, and represent a potential starting point for the develop-
ment of new drugs to combat important nematode infections.
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